USFDA issues 'Form 483' with three observations to Lupin US facility
New Delhi, April 18 (IANS) Major drug maker Lupin on Saturday said that the US health regulator has issued a 'Form 483' ...
New Delhi, April 18 (IANS) Major drug maker Lupin on Saturday said that the US health regulator has issued a 'Form 483' ...
New Delhi: Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USF...
Zydus Lifesciences is in focus after receiving USFDA clearance with zero observations for its Ahmedabad facility and lau...
Indoco Remedies has secured approval from the US health regulator for its generic Lacosamide oral solution. This medicat...